Author

L. I. Piechaczyk

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B.-T. Gjertsen· 1 shared D. S. Tadele· 1 shared J. M. Enserink· 1 shared J. M. Robertson· 1 shared J. Skavland· 1 shared J. Wesche· 1 shared M. C. Herrera· 1 shared M. Chlubnova· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B.-T. Gjertsen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A cell competition-based drug screen identifies a novel compound that induces dual c-Myc depletion and p53 activation

D. S. Tadele, J. M. Robertson, R. Crispin, M. C. Herrera, M. Chlubnova, L. I. Piechaczyk, P. Ayuda-Duran, S. K. Singh, T. Gedde-Dahl, Y. Floisand, J. Skavland, J. Wesche, B.-T. Gjertsen, J. M. Enserink

This study identifies a novel compound, DJ34, that depletes c-Myc and activates p53, showing strong activity against leukemic stem cells across multiple cancer types.

bioRxiv · May 16, 2020 · PreprintCancer Biology